STRENSIQ 28 mg/.7mL
ASFOTASE ALFA · SOLUTION · Alexion Pharmaceuticals, Inc.
No Recall History
Plain English
STRENSIQ is a solution containing asfotase alfa at 28 mg/.7mL, taken subcutaneous. Manufactured by Alexion Pharmaceuticals, Inc..
Key Facts
- Brand Name
- STRENSIQ
- Generic Name
- ASFOTASE ALFA
- NDC Code (Product)
25682-013- Manufacturer
- Alexion Pharmaceuticals, Inc.
- Strength
- 28 mg/.7mL
- Dosage Form
- SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125513
- Drug Class
- Tissue-nonspecific Alkaline Phosphatase [EPC]
- Marketing Start
- 10/23/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is STRENSIQ used for?
STRENSIQ contains ASFOTASE ALFA. It is a solution taken subcutaneous. Consult your doctor for specific uses.
Is STRENSIQ a controlled substance?
STRENSIQ is not classified as a controlled substance by the DEA.
What is the generic name for STRENSIQ?
The generic name for STRENSIQ is ASFOTASE ALFA. There are no other listed brand versions of ASFOTASE ALFA.
What is the NDC code for STRENSIQ 28 mg/.7mL?
The NDC (National Drug Code) for STRENSIQ 28 mg/.7mL is 25682-013, listed by Alexion Pharmaceuticals, Inc..
Other STRENSIQ Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)